WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2025 Issue has been successfully launched on 1 NOVEMBER 2025.

Abstract

ALPORT SYNDROME: A REVIEW

Dr. Reshma P. Varghese*, Dr. Kumar V., Dr. Kezia K. Sabu, Dr. Manojkumar S., Dr. Thirumurugan N., Dr. Shafrin Fathima A.S.

ABSTRACT

A rare inherited illness, following autosomal dominant polycystic kidney disease, is Alport Syndrome (AS). The disease spectrum is diverse, ranging from solitary microhaematuria to end- stage renal disease in early childhood. Its three distinct inheritance patterns are autosomal dominant, autosomal recessive and X- linked. In Europe, it represents 0.6%of all patients receiving renal replacement treatment.It is most frequently inherited as a 1 in 5000 gene- frequency X- linked disorder.

Keywords: Alport syndrome, COL4A, X-Linked, Hematuria.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More